Early-stage company support
IBRI supports selected early-stage companies with investment, talent, and space to accelerate drug discovery.
Source: LinkedIn company description · Retrieved October 13, 2026
The Indiana Biosciences Research Institute is a translational medicine institute advancing life sciences.
IBRI supports early-stage companies with investment, talent, and space to accelerate drug discovery. IBRI’s laboratories conduct research in diabetes, metabolic disease, Alzheimer’s disease, and rare pediatric diseases.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
IBRI supports selected early-stage companies with investment, talent, and space to accelerate drug discovery.
Source: LinkedIn company description · Retrieved October 13, 2026
IBRI’s public–private model bridges research-driven inquiry and profit-driven drug development while cultivating talent.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
Snapshot: September 28, 2026
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated August 31, 2026, September 4, 2026, September 16, 2026, September 28, 2026 and September 30, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.